Cyclo Therapeutics Price Patterns
| CYTHDelisted Stock | USD 0.72 0.06 9.09% |
Momentum 39
Sell Extended
Oversold | Overbought |
Using Cyclo Therapeutics hype-based prediction, you can estimate the value of Cyclo Therapeutics from the perspective of Cyclo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cyclo Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Cyclo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Cyclo Therapeutics after-hype prediction price | USD 0.72 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cyclo |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyclo Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Cyclo Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cyclo Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cyclo Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cyclo Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Cyclo Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cyclo Therapeutics' historical news coverage. Cyclo Therapeutics' after-hype downside and upside margins for the prediction period are 0.72 and 0.72, respectively. We have considered Cyclo Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Cyclo Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Cyclo Therapeutics is based on 3 months time horizon.
Cyclo Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Cyclo Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cyclo Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cyclo Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.72 | 0.72 | 0.00 |
|
Cyclo Therapeutics Hype Timeline
Cyclo Therapeutics is currently traded for 0.72. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Cyclo is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Cyclo Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.72. About 48.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.9. Cyclo Therapeutics last dividend was issued on the 9th of December 2020. The entity had 1:100 split on the 9th of December 2020. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.Cyclo Therapeutics Related Hype Analysis
Having access to credible news sources related to Cyclo Therapeutics' direct competition is more important than ever and may enhance your ability to predict Cyclo Therapeutics' future price movements. Getting to know how Cyclo Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cyclo Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IVC | Invacare | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ELUT | Elutia Inc | 0.03 | 6 per month | 4.93 | 0.13 | 9.78 | (7.25) | 33.48 | |
| RNLX | Renalytix AI | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LSB | LakeShore Biopharma Co | (0.03) | 7 per month | 8.14 | 0.02 | 12.33 | (12.50) | 91.99 | |
| ELEV | Elevation Oncology | 0.00 | 6 per month | 3.35 | 0.05 | 9.09 | (6.67) | 29.95 | |
| STRM | Streamline Health Solutions | 0.00 | 5 per month | 0.67 | 0.11 | 2.22 | (1.92) | 126.78 | |
| MSPR | MSP Recovery | 0 | 7 per month | 0.00 | (0.08) | 45.45 | (22.50) | 132.25 | |
| TRAW | Traws Pharma | (0.06) | 9 per month | 9.16 | 0.03 | 17.70 | (12.90) | 58.96 | |
| MEIP | MEI Pharma | (0.07) | 8 per month | 7.01 | 0.1 | 11.67 | (11.72) | 60.63 | |
| HEXO | Hexo Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cyclo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Cyclo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cyclo using various technical indicators. When you analyze Cyclo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cyclo Therapeutics Predictive Indicators
The successful prediction of Cyclo Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cyclo Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cyclo Therapeutics based on analysis of Cyclo Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cyclo Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cyclo Therapeutics's related companies.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Cyclo Stock
If you are still planning to invest in Cyclo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cyclo Therapeutics' history and understand the potential risks before investing.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |